Headline
GSK's $10.6bn cash bid for Nuvalent dominates the tape; Bellway flags April–May demand softening on mortgage rates while LBG Media cuts FY guidance.
What UK Plc said today
The session's defining move is GSK's $10.6bn ($124/share, 40% premium) all-cash acquisition of US oncology specialist Nuvalent, financed primarily from new and existing debt facilities — a transformative, patent-cliff-driven bet on two late-stage ROS1/ALK lung-cancer inhibitors, expected to close Q3 2026. BIOG and IBT confirm the transaction from the target/portfolio side.
On guidance, LBG is the standout negative: FY revenue cut to £100–107m (from £110m) and adjusted EBITDA to £15–20m (from £22m), with management citing Facebook algorithm impact and "AI Overviews" eroding web traffic — Direct revenue almost doubled but Indirect Social (-44%) and Indirect Web (-36%) overwhelmed it. BWY reaffirmed guidance but flagged demand "moderated in April and May in response to rising mortgage rates." FEVR reaffirmed market expectations at its AGM statement, noting Australia share gains and that it is "well hedged from a cost perspective."
Results: VNET swung to net cash (£0.44m) and lifted the dividend 84.6% to 2.40p on +1.5% revenue; ASIA hit first positive adjusted EBITDA ($1.3m) despite an 18% revenue decline; FCSS delivered +10.7% NAV return against MSCI China's +1.6%; LTI posted a -21.3% NAV total return and cut the final dividend to 28.0p (from 42.0p) as Lindsell Train Limited's AUM dropped to £7.0bn from £11.4bn.
Capital actions away from GSK: REL launched a £200m buyback, SSE priced €1.3bn of perpetual hybrid notes, NBS admitted €500m Tier 2 notes, and BREE completed a US$120m US aggregates bolt-on.
Statistical releases
No scheduled ONS releases today.
Policy / monetary
Nothing material from BoE. From HM Treasury HMT: Chancellor Rachel Reeves delivered a speech at the AI Adoption Summit; a new concierge service and visa scheme were unveiled to help fast-growing firms scale and attract talent; a small business regulatory taskforce was launched to reduce SME regulatory burdens; and Treasury published its database of independent UK economic forecasts.
Themes
UK consumer/housing fragility re-emerging. BWY's explicit call that "customer demand moderated in April and May in response to rising mortgage rates" is the cleanest read on the rate-sensitive consumer today — notable that reservations still sit above H1 levels, so this is softening, not collapse.
Structural digital-ad headwinds. LBG's downgrade is not cyclical: management cites Facebook algorithm instability and Google "AI Overviews" cutting search traffic. Read-across to any UK media name reliant on programmatic or referral traffic.
Big pharma reaching for the pipeline. GSK's $10.6bn move, financed largely with debt, signals willingness to pay 40% premiums for late-stage oncology assets ahead of patent cliffs — relevant context for sector M&A pricing.
Policy tilt to growth/SMEs. Three of four HMT items today (AI Adoption speech, SME taskforce, scale-up concierge/visa) point to a coordinated supply-side, pro-growth posture from the Treasury.
Watch
- NESF full-year results — 22 June 2026.
- SFR audited FY26 results and strategy update — 23 June 2026.
- REL £200m buyback programme completion — 26 June 2026.
- GYM H1 pre-close trading update — 8 July 2026.
- GSK/Nuvalent deal close expected Q3 2026, subject to HSR clearance.
- MYI new shares commence dealing 11 June 2026; RKW equity issue 10 June 2026.